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Little is known about the demographic and clinical differences between short and long duration of
untreated bipolar disorder (DUB) in Chinese patients. This study examined the demographic and clinical
features of short (≤2 years) and long DUB (>2 years) in China. A consecutively recruited sample of
555 patients with bipolar disorder (BD) was examined in 7 psychiatric hospitals and general hospital
psychiatric units across China. Patients’ demographic and clinical characteristics were collected using
a standardized protocol and data collection procedure. The mean DUB was 3.2 ± 6.0 years; long DUB
accounted for 31.0% of the sample. Multivariate analyses revealed that longer duration of illness,
diagnosis of BD type II, and earlier misdiagnosis of BD for major depressive disorder or schizophrenia
were independently associated with long DUB. The mean DUB in Chinese BD patients was shorter than
the reported figures from Western countries. The long-term impact of DUB on the outcome of BD is
warranted.
Bipolar disorder (BD) is a severe and chronic mental illness1 with the lifetime prevalence of BD type I (BD-I) and
type II (BD-II) being approximately 1.1% and 1.6%, respectively2. BD is often unrecognized or misdiagnosed. As
a consequence, BD has a long untreated period3–6, resulting in poor clinical outcomes including frequent recurrence and hospitalizations, suicidal behavior, high risk of rapid cycling and poor functional outcomes4,6,7.
Over the past decades several studies have been conducted in Western countries focusing on the duration of
untreated illness (DUI) defined as the interval between the onset of psychiatric disorders and the first treatment
received8. Commonly reported demographic and clinical correlates of DUI included BD-II, female gender, early
onset, depressive onset, long duration of illness, suicide attempts, family history of BD and co-morbid anxiety
disorders3,4,7,9. Recently the concept of duration of untreated bipolar disorder (DUB) has been recommended to
replace DUI4,7 to ensure a more accurate definition.
The prevalence and clinical features of mood disorders are affected by a host of biological and socio-cultural
factors, therefore findings obtained in Western settings are unlikely to be applicable to other parts of the world10.
Research findings in the Western world do not cover the full range of mood symptoms experienced by Chinese
patients11–15, which gave the impetus to conduct this study.
This study set out to examine the demographic and clinical features of Chinese patients with short (≤2 years)
and long (>2 years) DUB.
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Methods

Study participants and settings. This was a cross-sectional, multicenter study (Registration number:
NCT01770704) initiated by the Chinese Society of Psychiatry conducted in seven major psychiatric hospitals/
units located in the north, south, east, west and central parts of China representing a range of clinical settings.
Both inpatients and outpatients were consecutively screened during the study period (between January, 2013 and
January, 2014) with the following study entry criteria: age 18 years or older, diagnosis of BD-I or BD-II according
to DSM-IV criteria16 established by two consultant psychiatrists with over 15 years clinical experience, at least one
depressive or manic episode during the past year, understanding of the aims of the study and the contents of the
clinical interview and willingness to provide informed consent. The study protocol was approved by the Clinical
Research Ethics Committees of Beijing Anding Hospital, Peking University Institute of Mental Health, Shanghai
Mental Health Center, the Second Affiliated Hospital of Zhejiang University, Shenzhen Mental Health Centre,
Xijing Hospital and the First Affiliated Hospital of Kunming Medical University, China. The protocol including
the methods was performed in accordance with the Declaration of Helsinki and the relevant ethical guidelines
and regulations in China. Informed consents were obtained from all participants.
Assessment procedure. All patients with a diagnosis of BD receiving treatment in the participating hospitals/units were invited to take part in the study and if agreed, they were referred by their treating psychiatrists
to the investigators. Patients satisfying the above entry criteria were invited to participate in the study. Patients’
basic demographic and clinical data were collected with a form designed for the study in the course of a clinical
interview supplemented by a review of the medical records. DUB was defined as the interval between the onset
of the first mood episode and the first treatment with a mood stabilizer4,5. Mood stabilizers prescribed included
lithium, valproate, carbamazepine and lamotrigine. There is no widely accepted gold standard threshold for defining short/long DUB. Following earlier studies3 and the recommendation of the Chinese Society of Psychiatry
Expert Committee, in this study the 2-year cutoff point differentiated between short (≤2 years) and long DUB
(>2 years).
Statistical analysis.

The data were analyzed using SPSS Version 21.0 for Windows. Comparison of the
socio-demographic and clinical characteristics between the short and long DUB groups was made using independent sample t-test, Mann-Whitney U test, and chi-square test, as appropriate. Multiple logistic regression
analysis with the “Enter” method was used to determine the demographic and clinical variables that were independently associated with long DUB. Long DUB was the dependent variable, while variables that significantly
differed between the two groups in the above univariate analyses were entered as independent variables. The
one-sample Kolmogorov-Smirnov test was used to check the normality of the distribution of the continuous
variables. The level of significance set at 0.05 (two-tailed).

Results

Altogether 555 patients were invited to participate in the study; 35 (6.3%) refused thus 520 (93.7%) fulfilled the
study entry criteria and formed the study sample. The mean DUB was 3.2 ± 6.0 years. Long DUB accounted for
31.0% of the sample. Table 1 presents the basic demographic and clinical characteristics for the whole sample and
separately for patients with short and long DUB. Patients in the long DUB group were older, had a longer duration
of illness, more family history of mood disorders, more likely to have BD-II and an earlier misdiagnosis of BD for
major depressive disorder or schizophrenia.
Multivariate analyses revealed that longer duration of illness (p < 0.001, Odds ratio = 1.1, 95% CI =  1.1–1.2),
diagnosis of BD-II (p = 0.01, Odds ratio = 2.0, 95% CI = 1.2–3.6), earlier misdiagnosis of BD for major depressive disorder (p < 0.001, Odds ratio = 4.1, 95% CI = 2.4–7.3) or schizophrenia (p < 0.001, Odds ratio =  7.4, 95%
CI = 3.8–14.4) were independently and positively associated with long DUB, which accounted for a maximum of
42.7% of the model (p <  0.001) (Table 2).

Discussion

To the best of our knowledge, this was the first multicenter study in China that compared the demographic and
clinical features between BD patients with short and long DUB. The main finding is that Chinese BD patients
had a mean DUB of 3.2 years; 31.0% of the sample had long DUB. Long DUB was significantly associated with
longer duration of illness, diagnosis of BD type II, and earlier misdiagnosis of BD for major depressive disorder or
schizophrenia. The rate of participation in the study was high, reflecting a good relationship between patients and
their treating psychiatrists. Respect for the medical profession is still rather high in China – although it is being
eroded – and patients are unlikely to refuse a request from their doctors.
The mean DUB in this study was shorter than figures of 6.7–20 years reported from Western countries3–5,7,17,
but similar to the finding of 3.9 years reported from China18. The different definitions of DUB may partly account
for the inconsistency of the results. For example, studies used the interval between the first symptoms and diagnosis, but others referred to the time between the first episode and any treatment or prescription of mood stabilizers
in defining DUB4. Furthermore, there were more patients with BD-I than with BD-II in this sample (76.7% vs
23.3%), which would shorten DUB as BP-I patients are a great deal easier to identify3,19. In addition, the discrepancy in DUB between studies may be due to the differences in sampling methods, the distribution of bipolar subtypes and the type diagnostic assessment. All participating psychiatric units or hospitals in this study are located
in major cities thus patients could easily access mental health services. In addition, psychiatrists in major centres
are usually better trained to ascertain BD resulting in relatively short DUB.
In multivariate analyses DUB was independently associated with several clinical variables. Patients with longer
DUB had a longer duration of illness, which is consistent with earlier findings3. BD-II has been a major contributing factor to long DUB4,19,20, which is also confirmed in this study. Hypomania is often perceived as normal
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Variables

The whole sample (n = 520) DUB ≤ 2 years (n = 359) DUB > 2 years (n = 161)

P-value

Male, n (%)

252 (48.5)

176 (49.0)

76 (47.2)

0.70

Employed, n (%)

290 (55.8)

202 (56.3)

88 (54.7)

0.73

Living with family, n (%)

478 (91.9)

331 (92.2)

147 (91.3)

0.73

Family history of mood disorders, n (%)

70 (13.5)

38 (10.6)

32 (19.9)

0.004

181 (34.8)

119 (33.1)

62 (38.5)

Intermediate onset (21–37 yrs)

232 (44.6)

169 (47.1)

63 (39.1)

Late onset (>37 years)

107 (20.6)

71 (19.8)

36 (22.4)

Type I

399 (76.7)

288 (80.2)

111 (68.9)

Type II

121 (23.3)

71 (19.8)

50 (31.1)

Depressive

307 (59.0)

204 (56.8)

103 (64.0)

Manic/hypomanic/mixed

213 (41.0)

155 (43.2)

58 (36.0)

Major Depressive Disorder

270 (51.9)

166 (46.2)

104 (64.6)

<0.001

Schizophrenia

89 (17.1)

39 (10.9)

50 (31.1)

<0.001

Age at onset, n (%)
Early onset (≤21 yrs)

0.24

BD type, n (%)

0.005

Polarity of first mood episode, n (%)

0.12

History of misdiagnosis, n (%)

Anxiety disorders
Lifetime suicide attempts, n (%)
Comorbid substance abuse, n (%)

39 (7.5)

23 (6.4)

16 (9.9)

0.16

54 (10.4)

35 (9.7)

19 (11.8)

0.48

36 (6.9)

28 (7.8)

8 (5.0)

0.24

Mean ±  SD

Mean ±  SD

Mean ±  SD

P-value

DUB (years)

3.2 ±  6.0

0.3 ±  0.7

9.6 ±  7.7

—

Age (years)

35.1 ±  13.2

32.8 ±  12.4

40.3 ±  13.6

<0.001*

Education (years)

13.1 ±  3.4

13.2 ±  3.3

12.8 ±  3.6

0.41

Duration of illness (years)

6.4 ±  8.3

3.8 ±  6.2

12.3 ±  9.4

<0.001*

Number of admissions after the
diagnosis of BD

1.9 ±  1.5

2.0 ±  1.6

1.8 ±  1.3

0.13*

Table 1. Demographic and clinical characteristics of the sample. *Mann-Whitney U test. BD =  bipolar
disorder; DUB = duration of untreated bipolar disorder.
P value

Odds ratio

95% C. I.

0.44

1.0

0.9–1.02

<0.001

1.1

1.1–1.2

0.01

2.0

1.2–3.6

A history of misdiagnosis as major depressive disorder

<0.001

4.1

2.4–7.3

A history of misdiagnosis as schizophrenia

<0.001

7.4

3.8–14.4

0.35

1.3

0.7–2.5

Age (years)
Duration of illness (years)
BD-II

Family history of mood disorders

Table 2. Demographic and clinical characteristics independently associated with long DUB by multiple
logistic regression analysis. Study sites were controlled for. Total model: P <  0.001, R2 =  0.427.

condition by patients and their families, therefore it is not spontaneously reported21,22. Furthermore, depressive
episodes usually last longer than hypomania in BD-II, thus patients seek help for depression more often than for
hypomania23. Clinicians sometimes overlook the history of hypomania if patients present with a depressive episode. All these factors contribute to the failure to diagnose BD-II leading to an extended DUB.
Multiple episodes of major depression frequently occur prior to the first episode of hypomania or mania24,25. In
addition, depressive phases occur more frequently than hypomanic or manic phases26. Therefore BD is frequently misdiagnosed for major depressive disorder21,25,27, which, in turn, leads to longer DUB as found in this study. Similarly, BD
could manifest initially with psychotic symptoms prior to the first signs of mania that would suggest the diagnosis of
schizophrenia, which is another reason for longer DUB28. This is consistent with the finding of this study. Early onset of
BD (≤21 years) was reported to be a risk factor for long DUB4,29–32, but this was not confirmed in this study.
The major strength of this study is its large, multi-center sample. However, the results should be interpreted with
caution due to several methodological limitations. First, similar to most studies, some of the data were collected
retrospectively, such as onset age and that of the first episode, thus potential recall bias could not be avoided. Due to
logistical reasons, some important variables, such as genetic and neuroimaging data, could not be collected. Second,
due to the cross-sectional study design, the causality between DUB and other variables could not be examined.
Third, second-generation antipsychotics (SGAs) show certain mood-stabilizing properties. Considering that the
purpose of the SGA prescription were difficult to identify in cross-sectional surveys, only lithium, sodium valproate,
carbamazepine and lamotrigine were classified as mood stabilizers. Fourth, there is no widely accepted consensus
Scientific Reports | 7:44811 | DOI: 10.1038/srep44811
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regarding the definition of short/long DUB. Finally, following earlier studies4,5 prescription of mood stabilizers identified DUB although mood stabilizers do not necessarily indicate the diagnosis of BD.
In conclusion, the mean DUB in Chinese BD patients was shorter than the figures in the literature. The differences between long and short DUB with respect to Chinese BD patients’ demographic and clinical characteristics
were consistent with those found in Western clinical settings. Prospective studies examining the long-term clinical outcome of DUB are warranted.
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